688085.SH
三友医疗
SSE · Healthcare · Medical - Devices · CN
CNY 13.05
−3.33%Year over year
Reported trailing growth
- Revenue
- +13.7%
- EBITDA
- —
- EBIT
- +7.2%
- EPS
- +78.4%
- Free cash flow
- +190.3%
- Operating cash flow
- +37.8%
Forward estimates
Based on analyst estimates
- Revenue
- -76.4%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -5.8%
- EBITDA
- -26.3%
- EBIT
- -39.4%
- Net income
- -30.8%
- EPS
- -37.3%
- Free cash flow
- +30.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026